CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation
Public ClinicalTrials.gov record NCT01966367. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
CD34+ Stem Cell Selection for Patients Receiving a Matched or Partially Matched Family or Unrelated Adult Donor Allogeneic Stem Cell Transplantation for Non-Malignant Disease
Study identification
- NCT ID
- NCT01966367
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Diane George
- Other
- Enrollment
- 37 participants
Conditions and interventions
Conditions
- Acquired Immunodeficiency Syndromes
- Amegakaryocytic Thrombocytopenia
- Bone Marrow Failure Syndrome
- Diamond-Blackfan Anemia
- Familial Hemophagocytic Lymphocytosis
- Hemoglobinopathies
- Histiocytic Syndrome
- Langerhans Cell Histiocytosis (LCH)
- Lymphohistiocytosis
- Macrophage Activation Syndrome
- Primary Immunodeficiency Syndromes
- Schwachman Diamond Syndrome
- Severe Aplastic Anemia
- Severe Congenital Neutropenia
- Sickle Cell Disease
- Sickle Cell-beta-thalassemia
Interventions
- CD34 Stem Cell Selection Therapy Biological
Biological
Eligibility (public fields only)
- Age range
- Up to 40 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2013
- Primary completion
- Jan 31, 2030
- Completion
- Jan 31, 2030
- Last update posted
- Aug 13, 2025
2013 – 2030
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Morgan Stanley Children's Hospital, New York-Presbyterian, Columbia University | New York | New York | 10032 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01966367, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 13, 2025 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01966367 live on ClinicalTrials.gov.